U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
6600166001Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fasted ConditionsCompletedNo Results AvailableSeizuresDrug: Oxcarbazepinehttps://ClinicalTrials.gov/show/NCT01702623
6600266002Phase II Trial of Neo-adjuvant Temozolomide Prior to Combined Temozolomide and Concurrent Accelerated Hypofractionated External Beam Radiotherapy Followed by Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNo Results AvailableGlioblastoma MutliformeRadiation: IMRT Technique|Radiation: IMRT and accelerated hypofractionation technique|Radiation: neo-adjuvant TMZ followed by accelerated hypofractionated EBRT|Drug: Temozolomide and Accelerated Hypofractionation RThttps://ClinicalTrials.gov/show/NCT01702610
6600366003WBV and Acute Lateral Ankle SprainActive, not recruitingNo Results AvailablePostural Control|Subjective InstablityDevice: Whole body vibration (Galileo® Med M Plus, Novotec, Pforzheim, Germany)|Other: Physiotherapyhttps://ClinicalTrials.gov/show/NCT01702597
6600466004Efficacy and Safety of StENt-assisted Treatment for CErebral AneurysmsRecruitingNo Results AvailableStent EmbolisationProcedure: stent assisted embolizationhttps://ClinicalTrials.gov/show/NCT01702584
6600566005A Study of Kadcyla (Trastuzumab Emtansine) in Patients With HER2 Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based TreatmentRecruitingNo Results AvailableBreast CancerDrug: Kadcyla (trastuzumab emtansine)https://ClinicalTrials.gov/show/NCT01702571
6600666006A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Patients With HER2-Positive Metastatic Breast Cancer and Patients With HER2-Positive Locally Advanced / Metastatic Gastric CancerRecruitingNo Results AvailableBreast Cancer, Gastric CancerDrug: capecitabine|Drug: capecitabine|Drug: trastuzumab emtansine [Kadcyla]|Drug: trastuzumab emtansine [Kadcyla]|Drug: trastuzumab emtansine [Kadcyla]https://ClinicalTrials.gov/show/NCT01702558
6600766007Determination of Drugs and Their Metabolites in Hospitalized PatientsRecruitingNo Results AvailableNeoplasmshttps://ClinicalTrials.gov/show/NCT01702545
6600866008Nicotine Mouth Film for Craving Relief.CompletedHas ResultsSmoking CessationDrug: Nicotinehttps://ClinicalTrials.gov/show/NCT01702532
6600966009A Pharmacokinetic Evaluation of Two Nicotine Patches in SmokersCompletedHas ResultsSmokingDrug: nicotinehttps://ClinicalTrials.gov/show/NCT01702519
6601066010Evaluation Of The Potential Effect That The Administration Of Food Or Antacid Medication May Have In The Oral Absorption Of Dacomitinib (PF-00299804)CompletedNo Results AvailableHealthy VolunteersDrug: dacomitinib fasted|Drug: dacomitinib fed|Drug: dacomitinib+antacidhttps://ClinicalTrials.gov/show/NCT01702506
6601166011A Study to Assess the Relative Bioavailability of New Oral Formulations of SRT2104 in Healthy Male VolunteersCompletedNo Results AvailablePsoriasisDrug: Cap SRT2104|Drug: Tab SRT2104 slow release|Drug: Tab SRT2104 intermediate release|Drug: Tab SRT2104 fast release|Drug: Selected formulations of SRT2104 from Part 1|Drug: Selected formulations of SRT2104 from Part 1 single alternative dosehttps://ClinicalTrials.gov/show/NCT01702493
6601266012Effects of Triglycerides on Age-Related Cognitive Function Decline in Older SubjectsCompletedNo Results AvailableAlzheimer's DiseaseDrug: GSK2981710|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01702480
6601366013Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single, Oral Escalating Doses of GSK2647544 in Healthy VolunteersCompletedNo Results AvailableAlzheimer's DiseaseDrug: GSK2647544|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01702467
6601466014Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345CompletedHas ResultsInfluenzaBiological: Fluarix Quadrivalenthttps://ClinicalTrials.gov/show/NCT01702454
6601566015Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular EdemaCompletedNo Results AvailableDiabetic Macular Edema (DME)Drug: Subcutaneous AKB-9778https://ClinicalTrials.gov/show/NCT01702441
6601666016Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix®) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M M R®II), in Children 12 to 15 Months of AgeCompletedNo Results AvailableRubella|Measles|MumpsBiological: GSK Biologicals measles, mumps and rubella vaccine live (GSK 209762)|Biological: Merck & Co., Inc.'s M-M-R®II (also called M-M-R Vax Pro®), combined measles-mumps-rubella virus vaccine|Biological: Varivax® (Merck & Co., Inc.)|Biological: Havrix®|Biological: Prevnar 13® (Pfizer Inc.)https://ClinicalTrials.gov/show/NCT01702428
6601766017Zoledronic Acid in Cystic FibrosisWithdrawnNo Results AvailableCystic FibrosisDrug: Zoledronic acidhttps://ClinicalTrials.gov/show/NCT01702415
6601866018Operations Research to Address Unmet Need for Contraception in the Postpartum Period in Sylhet District, BangladeshCompletedNo Results AvailableHealth Knowledge, Attitudes, PracticeBehavioral: Educational and Behavior Change intervention|Other: Comparison Grouphttps://ClinicalTrials.gov/show/NCT01702402
6601966019Opioid-induced Hyperalgesia After Remifentanil InfusionCompletedNo Results AvailableHyperalgesiaDrug: Remifentanilhttps://ClinicalTrials.gov/show/NCT01702389
6602066020This Study Will Investigate the Effect of Single Oral Doses of Retosiban on Cardiac Repolarization, With Moxifloxacin as a Positive Control in Healthy Volunteers.CompletedNo Results AvailableObstetric Labour, PrematureDrug: Retosiban 100 mg|Drug: Retosiban 800 mg|Drug: Placebo|Drug: Moxifloxacin 400 mghttps://ClinicalTrials.gov/show/NCT01702376
6602166021Long-term Safety Study for GSK573719 in JapaneseCompletedHas ResultsPulmonary Disease, Chronic ObstructiveDrug: GSK573719https://ClinicalTrials.gov/show/NCT01702363
6602266022A Four Part Study to Investigate Relative Bioavailability, Safety and Tolerability of up to 5 Oral Formulation of GSK2251052 in Order to Identify a Formulation for Further Evaluation in a Future Later Phase StudyTerminatedNo Results AvailableCommunity-acquired InfectionDrug: GSK2251052https://ClinicalTrials.gov/show/NCT01702350
6602366023Prevalence-based Health and Economic Model of the Bivalent Versus the Quadrivalent Human Papillomavirus (HPV) VaccineCompletedNo Results AvailableHuman Papillomavirus InfectionOther: Prevalence-based modelhttps://ClinicalTrials.gov/show/NCT01702337
6602466024Evaluation of DD-25 Topical Cream for the Treatment of Psoriasis Vulgaris : Proof of Concept StudyRecruitingNo Results AvailablePsoriasis VulgarisDrug: DD-25https://ClinicalTrials.gov/show/NCT01702324
6602566025Point-of-Care Glucose Testing and Insulin SupplementationCompletedHas ResultsDiabetesDrug: Bedtime insulin Aspart (Novolog)https://ClinicalTrials.gov/show/NCT01702311
6602666026A Study to Assess the Safety and Tolerability of Sitagliptin/Simvastatin Fixed-dose Combination (FDC) in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-312)CompletedHas ResultsType 2 Diabetes MellitusDrug: Sitagliptin 100 mg/simvastatin 40 mg FDC|Drug: Metforminhttps://ClinicalTrials.gov/show/NCT01702298
6602766027Phase I Study to Assess the Safety, Tolerability, and Pharmacokinetics of Orally Administered CUDC-101 in Cancer PatientsTerminatedNo Results AvailableCancerDrug: CUDC-101https://ClinicalTrials.gov/show/NCT01702285
6602866028Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican and US Blood Donors - CTSCompletedNo Results AvailableDengueDevice: Procleix Dengue Virus Assayhttps://ClinicalTrials.gov/show/NCT01702272
6602966029Study of the Effect of Low Level Laser Light Therapy on Reducing the Appearance of Cellulite in the Thighs and Buttocks.CompletedNo Results AvailableCelluliteDevice: Erchonia Scanner device (GLS)|Device: Placebo devicehttps://ClinicalTrials.gov/show/NCT01702259
6603066030Effect of Simvastatin Treatment on Vaso-occlusive Pain in Sickle Cell DiseaseRecruitingNo Results AvailableSickle Cell DiseaseDrug: Simvastatinhttps://ClinicalTrials.gov/show/NCT01702246

* Görseller ve İçerik tekif hakkına sahip olabilir